CRYSTALLINE PI3 KINASE INHIBITORS
There is provided inter alia 6 (2 ((4 arnino 3 (3 hydroxyphenyl) 1 H pyrazolo[3 4 d]pyrirnidin 1 yl) methyl) 3 (2 chlorobenzyl) 4 oxo 3 4 dihydroquinazolin 5 yl) N N bis(2 methoxyethyl)hex 5 ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also pr...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | There is provided inter alia 6 (2 ((4 arnino 3 (3 hydroxyphenyl) 1 H pyrazolo[3 4 d]pyrirnidin 1 yl) methyl) 3 (2 chlorobenzyl) 4 oxo 3 4 dihydroquinazolin 5 yl) N N bis(2 methoxyethyl)hex 5 ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms. |
---|